What 9 Analyst Ratings Have To Say About Amedisys


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


Amedisys (NASDAQ:AMED) has observed the following analyst ratings within the last quarter:

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings13401
Last 30D00100
1M Ago00101
2M Ago13200
3M Ago00000

According to 9 analyst offering 12-month price targets in the last 3 months, Amedisys has an average price target of $219.11 with a high of $265.00 and a low of $150.00.

Below is a summary of how these 9 analysts rated Amedisys over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the move negative analysts are on the stock

This current average represents a 32.16% increase from the previous average price target of $323.0.

Analyst Ratings: What Are They?

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.

Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Analyst RatingsBZI-AAR